Koga, Japan

Eisuke Kojima


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1990-1994

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Eisuke Kojima: Innovator in Pharmaceutical Chemistry

Introduction

Eisuke Kojima is a prominent inventor based in Koga, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of 8 patents to his name, Kojima's work has had a substantial impact on the industry.

Latest Patents

Kojima's latest patents include innovative compounds such as cyclic aminophenylacetic acid derivatives and cyclic anthranilic acid derivatives. One notable patent describes an antirheumatoid pharmaceutical composition that contains a cyclic anthranilic acid derivative. This composition features a complex formula with various substituents, including hydrogen atoms, halogen atoms, and lower alkyl groups, among others. The detailed structure of these compounds showcases Kojima's expertise in creating effective pharmaceutical solutions.

Career Highlights

Eisuke Kojima is currently associated with Kyorin Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in the creation of new therapeutic agents that address various medical conditions. Kojima's dedication to innovation in pharmaceutical chemistry has earned him recognition within the scientific community.

Collaborations

Throughout his career, Kojima has collaborated with notable colleagues, including Katsuya Awano and Koji Saito. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking discoveries in the field.

Conclusion

Eisuke Kojima's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His ongoing work promises to yield further advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…